Literature DB >> 16365341

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16365341      PMCID： PMC1876394          DOI： 10.1136/hrt.2005.079988

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  254 in total

1.  Angiotensin receptor blockers and myocardial infarction.

Authors:  Subodh Verma; Marty Strauss
Journal:  BMJ       Date:  2004-11-27

Review 2.  Recent hypertension trials: implications and controversies.

Authors:  Bryan Williams
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

3.  Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group.

Authors:  F Gueyffier; C Bulpitt; J P Boissel; E Schron; T Ekbom; R Fagard; E Casiglia; K Kerlikowske; J Coope
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

4.  Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

Authors:  K Malmberg; L Rydén; H Wedel; K Birkeland; A Bootsma; K Dickstein; S Efendic; M Fisher; A Hamsten; J Herlitz; P Hildebrandt; K MacLeod; M Laakso; C Torp-Pedersen; A Waldenström
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

5.  Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.

Authors:  Rakesh S Birjmohun; Barbara A Hutten; John J P Kastelein; Erik S G Stroes
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

6.  A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.

Authors:  Thomas A Pearson; Margo A Denke; Patrick E McBride; Wendy P Battisti; William E Brady; Joanne Palmisano
Journal:  Mayo Clin Proc       Date:  2005-05       Impact factor: 7.616

7.  Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.

Authors:  W A Wilmer; L A Hebert; E J Lewis; R D Rohde; F Whittier; D Cattran; A S Levey; J B Lewis; S Spitalewitz; S Blumenthal; R P Bain
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

8.  The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation.

Authors:  Rolf Vogel; Andreas Indermühle; Jessica Reinhardt; Pascal Meier; Patrick T Siegrist; Mehdi Namdar; Philipp A Kaufmann; Christian Seiler
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

Review 9.  Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.

Authors:  Pierre Amarenco; Julien Labreuche; Philippa Lavallée; Pierre-Jean Touboul
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

10.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245
View more
  256 in total

1.  Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.

Authors:  Mandip S Dhamoon; Mitchell S V Elkind
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

2.  Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements.

Authors:  Roderick E Warren; Tom Marshall; Paul L Padfield; Sigrun Chrubasik
Journal:  Br J Gen Pract       Date:  2010-09       Impact factor: 5.386

3.  Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes.

Authors:  C Delles; A G Jardine
Journal:  Diabetologia       Date:  2010-10-13       Impact factor: 10.122

4.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

5.  Trends in age-standardised and age-specific mortality from ischaemic heart disease in Germany.

Authors:  Falk Müller-Riemenschneider; Frank Andersohn; Stefan N Willich
Journal:  Clin Res Cardiol       Date:  2010-03-24       Impact factor: 5.460

6.  Should we lower cholesterol as much as possible? Policy on high dose statins is startlingly absent.

Authors:  Martin G Duerden
Journal:  BMJ       Date:  2006-06-17

7.  The PROACTIVE Study and reduction of cardiovascular events in patients with diabetes.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

8.  Diabetes and lipid lowering: where are we?

Authors:  John P D Reckless
Journal:  BMJ       Date:  2006-05-13

9.  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.

Authors:  Vasilios G Athyros; Anna I Kakafika; Athanasios A Papageorgiou; Konstantinos Tziomalos; Athanasios Skaperdas; Efstathios Pagourelias; Athina Pirpasopoulou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Lipids       Date:  2007-08-23       Impact factor: 1.880

10.  Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery.

Authors:  Willem-Jan Flu; Sanne E Hoeks; Jan-Peter van Kuijk; Jeroen J Bax; Don Poldermans
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.